Saniona AB (FRA:30S) Tariff Resilience Score: 0/10 (As of Jul. 11, 2026)


FRA:30S Saniona AB FRA:30S
58 GF Score
Price €1.14
GF Value €2.34
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Tariff Resilience Score?

Saniona AB has the Tariff Resilience Score of 0, which implies that the company might have .

Saniona AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Saniona AB might have .

Saniona AB  (FRA:30S) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Saniona AB Tariff Resilience Score Related Terms

FRA:30S
58GF Score
Saniona AB FRA:30S
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Saniona AB (FRA:30S) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of €1.14 is trading 51.2% below its estimated GF Value™ of €2.34. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for FRA:30S:

  • Tariff Resilience Score: 0
  • GF Value™: €2.34 vs. price of €1.14 (51.2% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the FRA:30S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
58GF Score

Get the complete analysis for FRA:30S

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.14
Price
€2.34
GF Value